P is one of the major causes of drugchest pain and was admitted to our hospital. An induced lupus erythematosus (DIL) [1] . Patients taking electrocardiogram showed monomorphic ventricular procainamide for prolonged periods often develop tachycardia ( VT; heart rate 150/min), which was sucanticardiolipin antibodies, as well as anti-DNA and cessfully treated with 600 mg of i.v. procainamide. anti-histone antibodies [1] [2] [3] . Some of these patients
Echocardiogram and right ventriculogram with cardiac manifest thrombosis, as a part of drug-induced anticatheterization showed dilatation of the right atrium phospholipid syndrome (DI-APS) [2] [3] [4] [5] [6] . However, the and right ventricle. A biopsy from the right ventricular frequency of thrombotic events in these patients is myocardium revealed localized myocardial fibrosis. considered to be less than that seen in antiphospholipid Treatment with 2000-3000 mg/day of procainamide syndrome (APS) associated with systemic lupus erythsuccessfully suppressed ventricular arrhythmias. ematosus (SLE) [3] [4] [5] 7] .
In May 1993, he noticed a new skin ulcer on his left Systemic sclerosis (SSc) is another autoimmune distoe. Beraprost sodium (120 mg/day) and i.v. lipoease of unknown aetiology. Its primary site of injury prostaglandin E 1 ( lipo-PGE 1 ; 10 mg/week) did not is the vascular system, especially at the microvascular improve the ulcer, and he was admitted to our hospital level. Raynaud's phenomenon and digital tip ischaemia on 16 July 1993. Physical examination demonstrated are commonly seen [8] . However, digital gangrene skin sclerosis of the face, extremities and trunk. An which often requires amputation ensues in a few SSc ulcer with necrotic tissue on his left second toe was patients [8] , mainly in patients with limited cutaneous found ( Fig. 1) . Pulsation of dorsal pedal arteries was involvement [9] . not palpable bilaterally. Tenderness was observed in We present a patient with SSc with diffuse cutaneous his proximal interphalangeal and metacarpophalangeal involvement (dcSSc) who later developed a toe ganjoints. Facial erythema, alopecia and oral ulcers were grene, arthritis and pancytopenia as the manifestations not found. Laboratory testing revealed pancytopenia of APS and lupus-like syndrome after the administra-(white blood cell count 3600/ml, haemoglobin 8.6 g/dl tion of procainamide for the treatment of a ventricular and platelet count 80 000/ml ), a prolonged activated arrhythmia.
partial thromboplastin time (aPTT >150 s) and prolonged prothrombin time (PT, 26%) and decreased CASE REPORT levels of several coagulation factors (both FXI and A 51-yr-old Korean man had experienced Raynaud's FXII 28% of normal controls). The plasma von phenomenon since 1977 (at the age of 36 yr). He
Willebrand factor concentration was increased to 214% first visited our hospital in 1980 because of susof normal controls. The serum creatinine concentration tained Raynaud's phenomenon. Physical examination was increased (1.4 mg/dl ) and the glomerular filtration revealed acrosclerosis with pigmentation and depigrate was decreased (44 ml/min). The serum C-reactive mentation; digital tip ulcers and pitting scars; telangiecprotein (CRP) was elevated (6.22 mg/dl ), with hypertasia in the face, V-neck area and palms; and shortening gammaglobulinaemia (IgG 2736 mg/dl ) and hypocomof the sublingual fold. Bibasilar pulmonary fibrosis plementaemia (C3 31 mg/dl, C4 13 mg/dl ). Positive was recognized on chest radiographs. Serological tests circulating immune complexes (24.1 mg/ml by anti-C3d demonstrated anti-DNA topoisomerase I (formerly methods; normal <13 mg/ml ) and mixed-type cryoScl-70) antibodies (anti-DNA topo I ), but not antiglobulinaemia (IgG 3.0 mg/dl, IgA 0.3 mg/dl and IgM DNA antibodies (Farr's assay) nor lupus eryth-2.7 mg/dl ) were observed. The urinalysis was normal. ematosus (LE ) cells. He was diagnosed as having SSc At this point, antinuclear antibodies (ANA) and antiaccording to the preliminary criteria of the ARA [10] .
DNA topo I were positive, and LE cell preparation Skin sclerosis and pulmonary fibrosis progressed was also positive. Moreover, the serum anti-DNA gradually during the next 5 yr. Treatment with antibodies (Farr's assay) were positive, with a high 100 mg/day of -penicillamine was begun in May 1990.
titre of anti-single-stranded DNA antibodies (antiOn 27 July 1991, the patient experienced anterior ssDNA; 452.9 AU/ml; normal <10 AU/ml ), whereas anti-double-stranded DNA antibodies (anti-dsDNA) Submitted 11 March 1998 ; revised version accepted 18 June 1998.
were 76.3 AU/ml (normal <10 AU/ml ). Anti-U1 patient's sera. These strips were incubated for 2 h, then washed three times and incubated in a 1:7500 dilution of alkaline phosphatase- antibodies were also detected by immunoblotting ( Fig. 2) . These serological abnormalities have not been observed before procainamide administration AZ therapy, although the titre of anti-ssDNA, antidsDNA and anti-b 2 -GPI decreased (59.4 AU/ml, 14.7 except for positive tests for anti-DNA topo I. The human leucocyte antigen (HLA) genotyping demon-AU/ml and 25.0 U/ml, respectively). Procainamide was withdrawn on 1 November 1993. Mexiletine was strated HLA-DRB1*1502/0901, DQB1*0601/0303 and DPB1*0501/0901. started, but was changed to propafenon because of an allergic skin reaction. After discontinuing procainThe diagnosis of DIL and DI-APS was made. Although procainamide was highly suspected to be the amide, the patient's general condition improved remarkably. His pancytopenia, coagulopathy and renal causative agent, there was a possibility of recurrent VT after the cessation of procainamide, which led us dysfunction resolved as well. Serum levels of antissDNA as well as anti-dsDNA, anti-b 2 -GPI and antito continue it. Prednisolone (PSL) 30 mg/day and azathioprine (AZ ) 50 mg/day were administered histone antibodies finally decreased to normal levels (Fig. 2) . Repeated angiographs showed narrow but together in addition to daily infusion of lipo-PGE 1 . Angiography was performed, which showed occlusions patent anterior tibial arteries bilaterally. He was discharged on 26 January 1994, and has been doing well of anterior tibial arteries bilaterally and narrowing of digital arteries. His digital ulcer and necrosis prosince then. gressed, as did his renal dysfunction (serum creatinine DISCUSSION 2.3 mg/dl ) without hypertension, deterioration of thrombocytopenia, or increased plasma renin activity. This is the first case report of a patient with SSc who developed DIL and DI-APS. In our patient, Moreover, pancytopenia, especially thrombocytopenia, was sustained for over 3 months regardless of PSL and procainamide was used to treat VT which was attrib-uted to fibrosis in the right ventricle, possibly a cardiac also had this allele (HLA-DQB1*0303) suggests that there may be a common immunogenetic susceptibility manifestation of SSc. Procainamide is frequently associated with the development of a lupus-like syndrome between APS and DI-APS. The most interesting point in this case is that drug-[1]. ANA develop in 90% of procainamide-treated patients within 1 yr, and~30% will subsequently induced immune disorders ( lupus and APS) overlapped with an idiopathic autoimmune disease (SSc). develop procainamide-induced lupus (PIL) [1] . In patients with PIL, fever, serositis, leucopenia and posiWe have recently reported three cases having both serum anti-DNA topo I and anti-Sm antibodies, all of tive test for the LE cell preparation are frequently found, while malar rash, renal and central nervous whom had multiple serious organ involvements and thus poor prognosis associated with both of these two system (CNS) diseases are rare [1] . Anti-histone antibodies, especially anti-H2A-H2B complex, are usually antibodies [18] . In the present case, likewise, both SSc vasculopathy in digital arteries and occlusions in found in PIL, and anti-ssDNA are more frequently detected than anti-dsDNA in DIL, although those anterior tibial arteries as a manifestation of APS seemed to have contributed additively to the developfindings cannot differentiate DIL from idiopathic SLE [1, 11, 12] . Our patient developed fever, arthritis, ment of a toe gangrene, which resulted in a digital amputation. digital gangrene, pancytopenia and hypocomplementaemia. Moreover, he had a positive test for the LE cell In summary, we presented the first case report of a patient with a 15 yr history of dcSSc who developed preparation, anti-DNA antibodies (the titre of antissDNA was higher than that of anti-dsDNA) and anti-DIL and DI-APS after procainamide treatment. The combination therapy with PSL and AZ failed to resolve histone antibodies. However, he never displayed a rash, CNS involvement, proteinuria nor urinary casts.
various manifestations such as pancytopenia, and the withdrawal of procainamide, in contrast, dramatically Finally, the clinical course of the lupus-like syndrome in our patient closely paralleled the administration improved the clinical course. DIL and DI-APS should be taken into consideration, as well as the overlap of procainamide, not of -penicillamine. Taken all together, the diagnosis of PIL was made.
syndrome with SLE and APS, in patients with SSc who develop lupus-like syndrome and thrombotic There have been a number of reports of antiphospholipid antibodies (APA) appearing during procainevents. amide treatment, although only a small portion of those patients actually manifested thrombotic events, A and procainamide has been shown to be the most We are grateful to Drs Yohko Kawai, Kiyoaki common drug implicated as being associated with the 
